$0.40 Earnings Per Share Expected for Heska Co. (HSKA) This Quarter

Brokerages forecast that Heska Co. (NASDAQ:HSKA) will post $0.40 earnings per share for the current quarter, according to Zacks. Two analysts have made estimates for Heska’s earnings, with the lowest EPS estimate coming in at $0.37 and the highest estimate coming in at $0.43. Heska reported earnings of $0.61 per share in the same quarter last year, which would indicate a negative year over year growth rate of 34.4%. The company is expected to issue its next earnings results on Tuesday, May 1st.

According to Zacks, analysts expect that Heska will report full-year earnings of $1.95 per share for the current year, with EPS estimates ranging from $1.90 to $2.00. For the next financial year, analysts expect that the firm will post earnings of $2.17 per share, with EPS estimates ranging from $2.13 to $2.20. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that that provide coverage for Heska.

How to Become a New Pot Stock Millionaire

Heska (NASDAQ:HSKA) last announced its earnings results on Wednesday, February 28th. The medical research company reported $0.63 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.56 by $0.07. The firm had revenue of $36.04 million for the quarter, compared to analysts’ expectations of $40.56 million. Heska had a return on equity of 16.23% and a net margin of 7.53%. The firm’s quarterly revenue was down 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.46 earnings per share.

Several research analysts have issued reports on HSKA shares. Sidoti raised Heska from a “neutral” rating to a “buy” rating and set a $94.00 price target on the stock in a report on Monday, February 5th. BidaskClub raised Heska from a “sell” rating to a “hold” rating in a report on Thursday, December 21st. B. Riley dropped their price target on Heska from $93.00 to $77.00 and set a “neutral” rating on the stock in a report on Thursday, March 1st. ValuEngine cut Heska from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Finally, Zacks Investment Research cut Heska from a “hold” rating to a “sell” rating in a report on Wednesday, January 3rd. Two analysts have rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. Heska currently has an average rating of “Hold” and a consensus target price of $104.08.

Hedge funds and other institutional investors have recently bought and sold shares of the business. TimesSquare Capital Management LLC purchased a new position in Heska during the 4th quarter worth approximately $23,831,000. Park West Asset Management LLC grew its position in Heska by 293.3% during the 4th quarter. Park West Asset Management LLC now owns 347,646 shares of the medical research company’s stock worth $27,885,000 after purchasing an additional 259,256 shares in the last quarter. Redmile Group LLC purchased a new position in Heska during the 4th quarter worth approximately $15,753,000. Atlantic Trust Group LLC purchased a new position in Heska during the 3rd quarter worth approximately $16,059,000. Finally, Neuberger Berman Group LLC grew its position in Heska by 34.2% during the 3rd quarter. Neuberger Berman Group LLC now owns 603,469 shares of the medical research company’s stock worth $53,160,000 after purchasing an additional 153,895 shares in the last quarter. 85.21% of the stock is currently owned by institutional investors.

Shares of NASDAQ HSKA traded down $0.42 during trading on Friday, hitting $74.50. The company had a trading volume of 72,705 shares, compared to its average volume of 92,128. The stock has a market capitalization of $553.35, a P/E ratio of 35.99, a P/E/G ratio of 2.07 and a beta of 0.65. Heska has a 52 week low of $56.59 and a 52 week high of $115.00.

TRADEMARK VIOLATION WARNING: “$0.40 Earnings Per Share Expected for Heska Co. (HSKA) This Quarter” was posted by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at https://www.tickerreport.com/banking-finance/3341808/0-40-earnings-per-share-expected-for-heska-co-hska-this-quarter.html.

Heska Company Profile

Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps.

Get a free copy of the Zacks research report on Heska (HSKA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Heska (NASDAQ:HSKA)

Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

8,380 Shares in American Campus Communities  Acquired by LPL Financial LLC
8,380 Shares in American Campus Communities Acquired by LPL Financial LLC
Intrexon  Shares Sold by LPL Financial LLC
Intrexon Shares Sold by LPL Financial LLC
LPL Financial LLC Buys Shares of 7,295 Donaldson
LPL Financial LLC Buys Shares of 7,295 Donaldson
LPL Financial LLC Acquires New Stake in ProShares MSCI Europe Dividend Growers ETF
LPL Financial LLC Acquires New Stake in ProShares MSCI Europe Dividend Growers ETF
Longer Investments Inc. Has $2.55 Million Position in Microsoft Co.
Longer Investments Inc. Has $2.55 Million Position in Microsoft Co.
Apple  Shares Bought by Lenox Wealth Management Inc.
Apple Shares Bought by Lenox Wealth Management Inc.


Leave a Reply

© 2006-2018 Ticker Report. Google+.